Pegylated agents
- Name
- Pegylated agents
- Accession Number
- DBCAT004540
- Description
Not Available
- Drugs
Drug Drug Description Egaptivon pegol Platelet aggregation, thrombosis and acute coronary syndromes Lexaptepid pegol Lexaptepid pegol has been used in trials studying the treatment of Anemia, Inflammation, Chronic Diseases, End Stage Renal Disease, and Anemia of Chronic Disease. Peginesatide Peginesatide is used for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis Lipegfilgrastim A medication used to reduce the duration of chemotherapy-induced neutropenia and incidence of febrile neutropenia in cytotoxic chemotherapy. Abicipar Pegol Abicipar Pegol has been used in trials studying the treatment of Macular Edema and Macular Degeneration. Elapegademase A recombinant adenosine deaminase used to treat adenosine deaminase severe combined immune deficiency. PEG-uricase Investigated for use/treatment in hyperuricemia. Antihemophilic factor (recombinant), PEGylated For the management of hemophilia A (congenital factor VIII deficiency) [FDA label], . This medication is a human antihemophilic factor indicated in adolescent and adult patients (12 years and older)... Eptacog alfa pegol (activated) Eptacog alfa pegol (activated) has been used in trials studying the prevention and treatment of Haemophilia A, Haemophilia B, Congenital Bleeding Disorder, Haemophilia B With Inhibitors, and Haemophilia A With... Pegademase A modified form of bovine adenosine deaminase used to treat adenosine deaminase deficiency, a condition which leads to the formation of adenosine metabolites which are cytotoxic to lymphocytes. Pegamotecan Pegamotecan has been used in trials studying the treatment of Cancer of Stomach, Sarcoma, Soft Tissue, and Gastroesophageal Cancer. Peginterferon beta-1a An interferon beta used to treat relapsing forms of multiple sclerosis. GlycoPEG-GCSF Investigated for use/treatment in adverse effects (chemotherapy) and neutropenics. Pegaptanib A selective vascular endothelial growth factor (VEGF) antagonist used for the treatment of neovascular (wet) age-related macular degeneration. Pegloticase A recombinant uricase used for the treatment of chronic gout in adult patients refractory to conventional therapy. Certolizumab pegol A tumor necrosis factor (TNF) blocker used to treat a variety of autoimmune and autoinflammatory conditions like Crohn's disease, rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, and plaque psoriasis. Pegnivacogin Investigated for use/treatment in thrombosis, coronary artery disease, and vascular diseases. Olaptesed Pegol Olaptesed Pegol has been investigated for the treatment of Hematopoietic Stem Cell Transplantation. Pegpleranib Investigated for use/treatment in macular degeneration and eye disorders/infections. Heptaethylene glycol Not Annotated Peg-100 stearate Not Annotated Pegsunercept Investigated for use/treatment in rheumatoid arthritis. Damoctocog alfa pegol A recombinant Factor VIII used to treat hemophilia A to control bleeding, perioperative bleeding, and also for prophylaxis of bleeding. Insulin peglispro Not Annotated Pegvaliase An enzyme used to treat phenylketonuria in patients with phenylalanine levels that are too high on current treatment. Methoxy PEG-12 retinamide Not Annotated Methoxy polyethylene glycol-epoetin beta A synthetic erythropoiesis stimulating agent (ESA) used to treat anemia associated with chronic kidney disease. Cepeginterferon alfa-2B Cepeginterferon alfa-2B is under investigation in clinical trial NCT01889433 (An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C). Nonacog beta pegol A recombinant coagulation Factor IX derivative used to treat hemophilia B. Pegaspargase A modified form of L-asparagine amidohydrolase used to treat acute lymphoblastic leukemia, which is dependent on an external source of asparagine. Polidocanol A sclerosing agent used for the treatment of uncomplicated spider veins and uncomplicated reticular veins, all less than 3 mm in diameter, in the lower extremity. Peginterferon alfa-2a A modified form of recombinant human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C viruses. Peginterferon alfacon-1 Investigated for use/treatment in hepatitis (viral, C). Peginterferon alfa-2b A purified form of human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C, genital warts, and some cancers. Propylene glycol A clear, colorless, viscous organic solvent and diluent used in pharmaceutical preparations. Polyethylene glycol A laxative used to treat constipation and used for bowel preparation before colonoscopies and other procedures. Polyethylene glycol 400 An ingredient used in a wide variety of medications, and is not an approved medication. Pegvisomant A growth hormone receptor antagonist used to treat acromegaly. Pegfilgrastim A recombinant human granulocyte colony stimulating factor used to stimulate the production of neutrophils and prevent febrile neutropenia or infections after myelosuppressive chemotherapy. Rurioctocog alfa pegol A pegylated recombinant human coagulation factor VIII used to treat and prevent bleeding episodes in patients 12 years and above with hemophilia A. Pegunigalsidase alfa A recombinant form of human α-galactosidase-A indicated for long-term enzyme replacement therapy in patients with Fabry disease. - Drugs & Drug Targets